
PRIX GALIEN USA
The Prix Galien USA is America’s preeminent prize acknowledging the leading-edge of scientific advances in life sciences since 2007
Join us for the exciting 2023 edition of the Prix Galien USA Awards which will take place this coming October 26th in New York. To broaden our recognition of the teams working tirelessly to change the lives of millions in the USA and around the world, this year the Galien Foundation is delighted to announce the inauguration of a new prize category dedicated to products for rare / orphan diseases. We look forward to seeing you there!
Submission is a simple, easy process. Watch our short 3-minute video for a complete explanation of your submission from login to submission, dashboard and upload of all required company assets.


Prix Galien USA 2022
Best Pharmaceutical Product, Lumakras®
Best Pharmaceutical Product
Best Biotechnology Product
Best Medical Technology
Best Digital Health Solution
Exscientia’s end-to-end AI-driven precision medicine platform -
Exscientia
Best Incubator / Accelerator / Equity
Best Startup
Pharma/Biotech:
Aurion Biotech
Medtech:
Quantum Surgical
Digital Health:
Akili Interactive

Dr. Michael ROSENBLATT, Senior Advisor at Flagship Pioneering, presenting the 2022 Best Biotechnology Product to Regeneron President and CSO George Yancopoulos

Roche Holding Board Member Bernard Poussot presents winners of the 2022 Accelerator/Incubator/Equity, Startup and Digital Health Prizes.
The Prix Galien USA Awards Ceremony launched in 2007, first honoring unique medical products, later devices, and finally, individuals who have impacted patient care through innovation. The Awards Ceremony and Dinner is held annually at the New York City Museum of Natural History following the Galien Forum, which launched in New York City in 2010 and has since been held every autumn the Alexandria Center for Life Science – New York City. We award prizes for Best Pharmaceutical Product, Best Biotechnology Product, and Best Medical Technology approved by the FDA in the past five years as well as Best Digital Health Solution, Best Incubator/Accelerator/Equity and best Startup. Up to three prizes may be awarded annually in each of these categories. The prizes are awarded by a prestigious committees including Nobel laureates, industry leaders and other highly distinguished individuals in the health sector. Learn about our charter and selection criteria.
Any team member having worked on a Prix Galien Winning or Prix Galien nominated product or device is considered an alumnus by the Galien Foundation. We encourage our alumni to take an active part in our growing community by telling their stories from challenge to change for the benefit of human health worldwide.

“The Prix Galien USA recognizes the important research necessary to develop innovative medicines and devices that have a lifesaving impact on individuals and families across the globe.”
- Kathleen Sebelius, Former US Secretary of Health and Human Services

“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”
- Barack Obama, President of the United States – 2008

“I welcome you to the annual Prix Galien awards for innovative excellence in biomedical products and health technologies. The awards are among the highest honors in science and commerce.”
- Jimmy Carter, US President
he Prize boasts an illustrious list of winners who have entered the Galien Foundation Hall of Fame. The winners archive traces the history of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.

The Prize is awarded in 14 countries worldwide. Winners are candidates for the bi-yearly International prize contending with all prize-winning innovations worldwide
The Prix Galien USA Awards committees include up to 13 esteemed leaders in the life sciences from the United States with one international member and one honorary member. Two committees judge three categories each.
JUDGES IN THE CATEGORIES:
Best Pharmaceutical Product, Best Biotechnology Product, and Best Product for Rare/Orphan Diseases:

MICHAEL ROSENBLATT, MD

LINDA B. BUCK, PhD

SUE DESMOND-HELLMAN, MD, MPh

LAURIE GLIMCHER, MD

MARY-CLAIRE KING, PhD

ROBERT S. LANGER, MD

CATO T. LAURENCIN, MD, PhD

STEVEN LESTER, MD

STANLEY B. PRUSINIER, MD

PHILIPP A. SHARP, PhD

MARC TESSIER-LAVIGNE, PhD
JUDGES IN THE CATEGORIES:
Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup:

BERNARD POUSSOT (Committee Chair)

ROCH DOLIVEUX

MIKAEL DOLSTEIN

ALEX GORSKY

PENNY HEATON

SHERI MACCOY

FRANCOIS MAISONROUGE

JOEL MARCUS

ELIAS ZERHOUNI
MEDICAL TECHNOLOGY SUB-COMMITTEE:
This sub-committee pre-screens all applications in the Medical Technology category before submission of the short list



INCUBATOR, ACCELERATOR, EQUITY, SUB-COMMITTEE:
This sub-committee pre-screens all applications in the IAE category before submission of the short list







STARTUP ADVISORY BOARD:
The Start-up advisory board pre-screens all applications in the StartUp category before submission of the short list












DIGITAL HEALTH ADVISORY BOARD:
The Digital Health advisory board pre-screens all applications in the Digital Health category before submission of the short list








